Eupraxia Pharmaceuticals ... (EPRX)
NASDAQ: EPRX
· Real-Time Price · USD
5.32
0.04 (0.76%)
At close: Aug 15, 2025, 3:49 PM
5.30
-0.43%
After-hours: Aug 15, 2025, 04:55 PM EDT
Eupraxia Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -6.77M | -7.53M | -5.99M | -6.06M | -8.15M | -4.35M | -11.57M | -7.83M | -4.96M | -9.08M | -4.79M | -6.28M | -3.76M | -3.78M | -5.14M | -5.6M | -8.86M |
Depreciation & Amortization | 46.49K | 54.51K | 37.76K | 57.51K | 50.46K | 7.82K | 49.91K | 49.19K | 48.62K | 55.12K | 49.89K | 48.9K | 39.37K | 41.41K | 29.57K | 20.31K | 20.24K |
Stock-Based Compensation | 1.49M | 1.03M | 507.25K | 1.47M | 213.13K | 320.1K | 481.91K | 685.23K | 317.42K | 956.01K | 159.78K | 272.03K | 526.34K | 545.72K | 429.82K | 527.93K | 2.71M |
Other Working Capital | -698.72K | -119.41K | -4.74M | -2.86M | 314.11K | 6.62K | 415.44K | 1.24M | -1.9M | 2M | -1.28M | 2.05M | -1M | -334.83K | 2.14M | n/a | n/a |
Other Non-Cash Items | -68.29K | -91.38K | -4.28K | -3.16M | -414.45K | -64.72K | -37.48K | 842.85K | 734.87K | 479.23K | 190.2K | 237.6K | 252.91K | 260.15K | 120.22K | 565.16K | 3.63M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -1.96M | 2.74M | -50.05K | -95.01K | 37.8K | -296.69K | -113.3K | 67.03K | 39.55K | -169.91K | 61.5K | 1.27M |
Change in Working Capital | -707.4K | 568.72K | -4.74M | -2.84M | 337.3K | 6.45K | 391.63K | 1.29M | -1.89M | 2.27M | -1.29M | 2.11M | -1.01M | -662.18K | 2.07M | 247.63K | -1.87M |
Operating Cash Flow | -6M | -5.97M | -10.19M | -10.54M | -8.25M | -6.11M | -7.95M | -5.69M | -6.16M | -5.29M | -5.88M | -3.72M | -3.88M | -3.55M | -2.48M | -4.23M | -4.37M |
Capital Expenditures | -169.04K | -44.31K | -42.27K | -10.85K | -9.16K | -49.69K | -12.75K | -8.55K | -10.89K | -85.21K | -50.77K | -165.61K | -6.78K | -18.07K | -408.47K | -1.33K | -3.8K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 310.00 | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 18M | n/a | -18M | n/a | -9M | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 50.38K | n/a | 9.01M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 558.00 | n/a | 28.51K | n/a | n/a | n/a | n/a | n/a | 22.63K | n/a | n/a | n/a | -9M | 41.05K | n/a | -5.06M |
Investing Cash Flow | -169.04K | -43.76K | -42.27K | 17.66K | -9.16K | -41.18K | -12.75K | -8.55K | -10.89K | 17.91M | -50.77K | -9.16M | -6.78K | -9.01M | -367.42K | -1.33K | -5.07M |
Debt Repayment | n/a | n/a | -4.6M | -4.5M | -27.71K | -37.52K | -26.81K | -26.45K | -35.62K | n/a | n/a | -23.43K | -36.17K | -78.13K | 421.07K | 9.28M | 2M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 429.92K | 25.86K | -6.22K | -231.68K | -21.94K | 140.79K | -6.02M | -21.92K | 298.64K | -47.87K | -46.8K | -21.92K | -8.99K | -26.36K | -21.92K | -563.04K | -7.87M |
Financial Cash Flow | 429.92K | 31.73M | -4.6M | -4.5M | 31.23M | 188.71K | 22.04M | 6.01M | 260.23K | 362.13K | -46.8K | 13.25M | -45.15K | -148.21K | 399.15K | 9.26M | 40.41M |
Net Cash Flow | -5.65M | 24.44M | -14.65M | -12.59M | 15.38M | -5.09M | 14.11M | 247.38K | -5.89M | 12.93M | -5.59M | 511.69K | -4.01M | -12.77M | -2.41M | 4.96M | 30.97M |
Free Cash Flow | -6.17M | -6.02M | -10.23M | -7.72M | -8.26M | -6.16M | -7.96M | -5.7M | -6.18M | -5.37M | -5.93M | -3.89M | -3.89M | -3.57M | -2.89M | -4.24M | -4.38M |